APO Research
Talk to an analyst

APO RESEARCH · REPORT

SARS-CoV-2 IgG (RBD) ELISA

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global SARS-CoV-2 IgG (RBD) ELISA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025191 pages

Choose your research edition.

Industry ResearchSARS-CoV-2 IgG (RBD) ELISA Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal SARS-CoV-2 IgG (RBD) ELISA Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal SARS-CoV-2 IgG (RBD) ELISA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SARS-CoV-2 IgG (RBD) ELISA Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal SARS-CoV-2 IgG (RBD) ELISA Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global SARS-CoV-2 IgG (RBD) ELISA market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for SARS-CoV-2 IgG (RBD) ELISA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for SARS-CoV-2 IgG (RBD) ELISA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SARS-CoV-2 IgG (RBD) ELISA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for SARS-CoV-2 IgG (RBD) ELISA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of SARS-CoV-2 IgG (RBD) ELISA include ALPCO, BD Biosciences, BioMérieux, Bio-Rad Laboratories, Enzo Life Sciences, LG, LOEWE Biochemica, Ortho Clinical Diagnostics and R&D Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global SARS-CoV-2 IgG (RBD) ELISA market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of SARS-CoV-2 IgG (RBD) ELISA and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents SARS-CoV-2 IgG (RBD) ELISA revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the SARS-CoV-2 IgG (RBD) ELISA market size, projected growth trends, production technologies, key applications, and end-use industries.

SARS-CoV-2 IgG (RBD) ELISA Segment by Company

ALPCO

BD Biosciences

BioMérieux

Bio-Rad Laboratories

Enzo Life Sciences

LG

LOEWE Biochemica

Ortho Clinical Diagnostics

R&D Systems

Shenzhen YHLO Biotech

ZEUS Scientific

Thermo Fisher Scientific

SARS-CoV-2 IgG (RBD) ELISA Segment by Type

ELISA Sets

ELISA Kits

SARS-CoV-2 IgG (RBD) ELISA Segment by Application

Hospital

Clinic

Disease control and prevention system

SARS-CoV-2 IgG (RBD) ELISA Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SARS-CoV-2 IgG (RBD) ELISA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SARS-CoV-2 IgG (RBD) ELISA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SARS-CoV-2 IgG (RBD) ELISA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of SARS-CoV-2 IgG (RBD) ELISA in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global SARS-CoV-2 IgG (RBD) ELISA industry.

Chapter 3: Detailed analysis of SARS-CoV-2 IgG (RBD) ELISA companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SARS-CoV-2 IgG (RBD) ELISArevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of ELISA Sets Table 3. Key Players of ELISA Kits Table 4. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Disease control and prevention system Table 8. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2021-2026) & (US$ Million) Table 10. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2021-2026) Table 11. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2027-2032) & (US$ Million) Table 12. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2027-2032) Table 13. SARS-CoV-2 IgG (RBD) ELISA Industry Trends Table 14. SARS-CoV-2 IgG (RBD) ELISA Industry Drivers Table 15. SARS-CoV-2 IgG (RBD) ELISA Industry Opportunities and Challenges Table 16. SARS-CoV-2 IgG (RBD) ELISA Industry Restraints Table 17. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (US$ Million) & (2021-2026) Table 18. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Company (2021-2026) Table 19. Global SARS-CoV-2 IgG (RBD) ELISA Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global SARS-CoV-2 IgG (RBD) ELISA Key Company Head Office and Area Served Table 21. Global SARS-CoV-2 IgG (RBD) ELISA Company, Product Type & Application Table 22. Global SARS-CoV-2 IgG (RBD) ELISA Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global SARS-CoV-2 IgG (RBD) ELISA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026) & (US$ Million) Table 27. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032) & (US$ Million) Table 28. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2021-2026) Table 29. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2027-2032) Table 30. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026) & (US$ Million) Table 32. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032) & (US$ Million) Table 33. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2021-2026) Table 34. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2027-2032) Table 35. ALPCO Company Information Table 36. ALPCO Business Overview Table 37. ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 39. ALPCO Recent Development Table 40. BD Biosciences Company Information Table 41. BD Biosciences Business Overview Table 42. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 44. BD Biosciences Recent Development Table 45. BioMérieux Company Information Table 46. BioMérieux Business Overview Table 47. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 49. BioMérieux Recent Development Table 50. Bio-Rad Laboratories Company Information Table 51. Bio-Rad Laboratories Business Overview Table 52. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 54. Bio-Rad Laboratories Recent Development Table 55. Enzo Life Sciences Company Information Table 56. Enzo Life Sciences Business Overview Table 57. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 59. Enzo Life Sciences Recent Development Table 60. LG Company Information Table 61. LG Business Overview Table 62. LG SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. LG SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 64. LG Recent Development Table 65. LOEWE Biochemica Company Information Table 66. LOEWE Biochemica Business Overview Table 67. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 69. LOEWE Biochemica Recent Development Table 70. Ortho Clinical Diagnostics Company Information Table 71. Ortho Clinical Diagnostics Business Overview Table 72. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 74. Ortho Clinical Diagnostics Recent Development Table 75. R&D Systems Company Information Table 76. R&D Systems Business Overview Table 77. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 79. R&D Systems Recent Development Table 80. Shenzhen YHLO Biotech Company Information Table 81. Shenzhen YHLO Biotech Business Overview Table 82. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 84. Shenzhen YHLO Biotech Recent Development Table 85. ZEUS Scientific Company Information Table 86. ZEUS Scientific Business Overview Table 87. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 89. ZEUS Scientific Recent Development Table 90. Thermo Fisher Scientific Company Information Table 91. Thermo Fisher Scientific Business Overview Table 92. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Portfolio Table 94. Thermo Fisher Scientific Recent Development Table 95. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026) & (US$ Million) Table 96. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032) & (US$ Million) Table 97. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026) & (US$ Million) Table 98. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032) & (US$ Million) Table 99. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) Table 101. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2027-2032) Table 102. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) Table 108. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2027-2032) Table 109. China SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026) & (US$ Million) Table 110. China SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032) & (US$ Million) Table 111. China SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026) & (US$ Million) Table 112. China SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) Table 119. Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. SARS-CoV-2 IgG (RBD) ELISA Product Image Figure 2. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Type: 2025 VS 2032 Figure 4. ELISA Sets Image Figure 5. ELISA Kits Image Figure 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Disease control and prevention system Image Figure 11. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 13. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players in 2025 Figure 16. Global Top 5 and 10 SARS-CoV-2 IgG (RBD) ELISA Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2021-2032) Figure 20. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2021-2032) Figure 22. North America SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 23. North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032) Figure 24. North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032) Figure 25. North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 26. United States SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 27. Canada SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 28. Mexico SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 29. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 30. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032) Figure 31. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032) Figure 32. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 33. Germany SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 34. France SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 35. U.K. SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 36. Italy SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 37. Russia SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 39. China SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 40. China SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032) Figure 41. China SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032) Figure 42. Asia SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 43. Asia SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032) Figure 44. Asia SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032) Figure 45. Asia SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 46. Japan SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 47. South Korea SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 50. India SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 51. Australia SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032) Figure 56. Brazil SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 57. South Africa SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 59. Turkey SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 60. Argentina SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 61. UAE SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 62. Egypt SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 63. Chile SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA Sets
  • ELISA Kits
Applications
  • Hospital
  • Clinic
  • Disease control and prevention system
Companies covered
  • ALPCO
  • BD Biosciences
  • BioMérieux
  • Bio-Rad Laboratories
  • Enzo Life Sciences
  • LG
  • LOEWE Biochemica
  • Ortho Clinical Diagnostics
  • R&D Systems
  • Shenzhen YHLO Biotech
  • ZEUS Scientific
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 ELISA Sets
  5. 1.2.3 ELISA Kits
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Disease control and prevention system
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global SARS-CoV-2 IgG (RBD) ELISA Growth Trends by Region
  13. 1.5.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2021-2026)
  15. 1.5.3 SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global SARS-CoV-2 IgG (RBD) ELISA Market Dynamics
  1. 2.1 SARS-CoV-2 IgG (RBD) ELISA Industry Trends
  2. 2.2 SARS-CoV-2 IgG (RBD) ELISA Industry Drivers
  3. 2.3 SARS-CoV-2 IgG (RBD) ELISA Industry Opportunities and Challenges
  4. 2.4 SARS-CoV-2 IgG (RBD) ELISA Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2026)
  2. 3.2 Global SARS-CoV-2 IgG (RBD) ELISA Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global SARS-CoV-2 IgG (RBD) ELISA Key Company Head office and Area Served
  4. 3.4 Global SARS-CoV-2 IgG (RBD) ELISA Company, Product Type & Application
  5. 3.5 Global SARS-CoV-2 IgG (RBD) ELISA Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global SARS-CoV-2 IgG (RBD) ELISA Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 SARS-CoV-2 IgG (RBD) ELISA Players Market Share by Revenue in 2025
  9. 3.6.3 2025 SARS-CoV-2 IgG (RBD) ELISA Tier 1, Tier 2, and Tier 3
4 SARS-CoV-2 IgG (RBD) ELISA Market by Type
  1. 4.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2032)
  3. 4.3 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Type (2021-2032)
5 SARS-CoV-2 IgG (RBD) ELISA Market by Application
  1. 5.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2032)
  3. 5.3 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ALPCO
  2. 6.1.1 ALPCO Company Information
  3. 6.1.2 ALPCO Business Overview
  4. 6.1.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  6. 6.1.5 ALPCO Recent Developments
  7. 6.2 BD Biosciences
  8. 6.2.1 BD Biosciences Company Information
  9. 6.2.2 BD Biosciences Business Overview
  10. 6.2.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  12. 6.2.5 BD Biosciences Recent Developments
  13. 6.3 BioMérieux
  14. 6.3.1 BioMérieux Company Information
  15. 6.3.2 BioMérieux Business Overview
  16. 6.3.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  18. 6.3.5 BioMérieux Recent Developments
  19. 6.4 Bio-Rad Laboratories
  20. 6.4.1 Bio-Rad Laboratories Company Information
  21. 6.4.2 Bio-Rad Laboratories Business Overview
  22. 6.4.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  24. 6.4.5 Bio-Rad Laboratories Recent Developments
  25. 6.5 Enzo Life Sciences
  26. 6.5.1 Enzo Life Sciences Company Information
  27. 6.5.2 Enzo Life Sciences Business Overview
  28. 6.5.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  30. 6.5.5 Enzo Life Sciences Recent Developments
  31. 6.6 LG
  32. 6.6.1 LG Company Information
  33. 6.6.2 LG Business Overview
  34. 6.6.3 LG SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 LG SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  36. 6.6.5 LG Recent Developments
  37. 6.7 LOEWE Biochemica
  38. 6.7.1 LOEWE Biochemica Company Information
  39. 6.7.2 LOEWE Biochemica Business Overview
  40. 6.7.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  42. 6.7.5 LOEWE Biochemica Recent Developments
  43. 6.8 Ortho Clinical Diagnostics
  44. 6.8.1 Ortho Clinical Diagnostics Company Information
  45. 6.8.2 Ortho Clinical Diagnostics Business Overview
  46. 6.8.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  48. 6.8.5 Ortho Clinical Diagnostics Recent Developments
  49. 6.9 R&D Systems
  50. 6.9.1 R&D Systems Company Information
  51. 6.9.2 R&D Systems Business Overview
  52. 6.9.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  54. 6.9.5 R&D Systems Recent Developments
  55. 6.10 Shenzhen YHLO Biotech
  56. 6.10.1 Shenzhen YHLO Biotech Company Information
  57. 6.10.2 Shenzhen YHLO Biotech Business Overview
  58. 6.10.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  60. 6.10.5 Shenzhen YHLO Biotech Recent Developments
  61. 6.11 ZEUS Scientific
  62. 6.11.1 ZEUS Scientific Company Information
  63. 6.11.2 ZEUS Scientific Business Overview
  64. 6.11.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  66. 6.11.5 ZEUS Scientific Recent Developments
  67. 6.12 Thermo Fisher Scientific
  68. 6.12.1 Thermo Fisher Scientific Company Information
  69. 6.12.2 Thermo Fisher Scientific Business Overview
  70. 6.12.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Portfolio
  72. 6.12.5 Thermo Fisher Scientific Recent Developments
7 North America
  1. 7.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032)
  2. 7.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
  3. 7.2.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026)
  4. 7.2.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032)
  5. 7.2.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032)
  6. 7.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
  7. 7.3.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026)
  8. 7.3.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032)
  9. 7.3.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032)
  10. 7.4 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country
  11. 7.4.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  13. 7.4.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2027-2032)
  14. 7.4.4 North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032)
  2. 8.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
  3. 8.2.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026)
  4. 8.2.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032)
  5. 8.2.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032)
  6. 8.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
  7. 8.3.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026)
  8. 8.3.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032)
  9. 8.3.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032)
  10. 8.4 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country
  11. 8.4.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  13. 8.4.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2027-2032)
  14. 8.4.4 Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032)
  2. 9.2 China SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
  3. 9.2.1 China SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026)
  4. 9.2.2 China SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032)
  5. 9.2.3 China SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032)
  6. 9.3 China SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
  7. 9.3.1 China SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026)
  8. 9.3.2 China SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032)
  9. 9.3.3 China SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032)
  2. 10.2 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
  3. 10.2.1 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026)
  4. 10.2.2 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032)
  5. 10.2.3 Asia SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032)
  6. 10.3 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
  7. 10.3.1 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026)
  8. 10.3.2 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032)
  9. 10.3.3 Asia SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032)
  10. 10.4 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Country
  11. 10.4.1 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  13. 10.4.3 Asia SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2027-2032)
  14. 10.4.4 Asia SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
  3. 11.2.1 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
  7. 11.3.1 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country
  11. 11.4.1 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst